Huyen Cao
Public Health Dayton & Montgomery County(US)
Publications by Year
Research Areas
HIV Research and Treatment, HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, COVID-19 Clinical Research Studies, Immune Cell Function and Interaction
Most-Cited Works
- → Compassionate Use of Remdesivir for Patients with Severe Covid-19(2020)2,902 cited
- → Remdesivir for 5 or 10 Days in Patients with Severe Covid-19(2020)1,431 cited
- → Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19(2020)1,265 cited
- → Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials(2015)593 cited
- → Depletion of Regulatory T Cells in HIV Infection Is Associated with Immune Activation(2005)363 cited
- → Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects(2020)262 cited
- Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial(2022)
- → Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy(2015)140 cited
- → Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor(2021)132 cited
- → Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial(2021)124 cited